A biopharmaceutical research and development company focused on commercializing proprietary product candidates for the treatment of cancer and infectious diseases.


Updates from The Motley Fool

Latest updates on Mast Therapeutics from Fool.com.


Stock Performance

MSTX vs. S&P 500 | 2 Year Performance
View Interactive MSTX Charts
Sponsored by

Key Data Points

Primary metrics and data points about Mast Therapeutics.
Current Price: $0.12
Prev Close: $0.13
Open: $0.13
Bid: $0.12
Ask: $0.12
Day's Range: $0.12 - $0.14
52wk Range: $0.10 - $0.71
Volume: 24,897,275
Avg Vol 12,024,303
Market Cap: $20.12M
P/E (ttm): -0.51
EPS (ttm): -$0.25
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Mast Therapeutics.
CAPS Rating 1 out of 5
 
104 Outperform
20 Underperform
CAPS All Stars
 
13 Outperform
10 Underperform

How do you think Mast Therapeutics will perform against the market?



You pick for Mast Therapeutics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Brian M. Culley, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Mast Therapeutics.

A biopharmaceutical research and development company focused on commercializing proprietary product candidates for the treatment of cancer and infectious diseases.

  • Exchange: NYSEMKT
  • Sector: Healthcare
  • Industry: Drug Makers